aap Implantate AG (ETR:AAQ1)
Germany · Delayed Price · Currency is EUR 1.460
0.00 (0.00%)
Oct 26, 2026, 5:35 PM CET
aap Implantate AG Revenue
aap Implantate AG had revenue of 6.52M EUR in the half year ending June 30, 2026, with 8.29% growth. This brings the company's total for the last twelve months to 12.76M, up 5.55% year-over-year. In the year 2025, aap Implantate AG had annual revenue of 12.28M with 1.69% growth. That makes aap Implantate AG the 35,861st largest company in the world by revenue and 505th in Germany.
Revenue (ttm)
12.76M
Revenue Growth
+5.55%
P/S Ratio
1.66
Revenue / Employee
116.26K
Employees
105
Market Cap
20.31M
Revenue by Geography
- EMEA (Europe Excluding Germany, Middle East, Africa) 3.81M 30.5%
- NA (North America) 2.80M 22.4%
- LATAM (Latin America) 2.49M 19.9%
- Germany 2.46M 19.7%
- APAC (Asia Pacific) 924.00K 7.4%
Fiscal year ended Dec 31, 2025 See the full aap Implantate AG breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.28M | 204.00K | 1.69% |
| Dec 31, 2024 | 12.07M | 576.00K | 5.01% |
| Dec 31, 2023 | 11.50M | -655.00K | -5.39% |
| Dec 31, 2022 | 12.15M | -567.00K | -4.46% |
| Dec 31, 2021 | 12.72M | 3.77M | 42.11% |
| Dec 31, 2020 | 8.95M | -4.05M | -31.16% |
| Dec 31, 2019 | 13.00M | 362.00K | 2.86% |
| Dec 31, 2018 | 12.64M | 971.00K | 8.32% |
| Dec 31, 2017 | 11.67M | -770.00K | -6.19% |
| Dec 31, 2016 | 12.44M | -21.47M | -63.32% |
| Dec 31, 2015 | 33.91M | -100.00K | -0.29% |
| Dec 31, 2014 | 34.01M | -7.03M | -17.14% |
| Dec 31, 2013 | 41.04M | -1.56M | -3.66% |
| Dec 31, 2012 | 42.60M | 7.69M | 22.01% |
| Dec 31, 2011 | 34.92M | -290.00K | -0.82% |
| Dec 31, 2010 | 35.21M | -2.25M | -6.00% |
| Dec 31, 2009 | 37.45M | -1.25M | -3.23% |
| Dec 31, 2008 | 38.71M | 3.68M | 10.50% |
| Dec 31, 2007 | 35.03M | 13.81M | 65.09% |
| Dec 31, 2006 | 21.22M | 4.11M | 24.03% |
| Dec 31, 2005 | 17.11M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.38B |
| Fresenius SE & Co. KGaA | 23.28B |
| Siemens Healthineers AG | 23.17B |
| Merck KGaA | 21.14B |
| Maternus-Kliniken Aktiengesellschaft | 119.35M |
| FamiCord AG | 87.78M |
| Biofrontera AG | 15.97M |
| MeVis Medical Solutions AG | 15.48M |